TwinKnowledge | $3,700,000 | (Apr 3, 2025)
Further AI | $5,000,000 | (Apr 3, 2025)
Vivere | $7,500,000 | (Apr 3, 2025)
Predicta Biosciences
United States
- Cambridge, Massachusetts
- 17/07/2024
- Seed
- $5,200,000
Predicta Biosciences is a precision oncology company integrating cutting edge multiomics and liquid biopsies to develop innovative diagnostic and therapeutic products. Predicta's diagnostic product portfolio removes the burden of bone-marrow biopsies, through small blood-based samples, and enables best-in-class treatment decision-making for immunotherapies. Utilizing the data from the diagnostic platform, Predicta has an in-house therapeutic pipeline of novel immunotherapy targets in pre-clinical discovery and development.
- Industry Biotechnology Research
- Website https://www.predictabiosciences.com/
- LinkedIn https://www.linkedin.com/company/predicta-biosciences/
Related People
Kate (Gallagher) CavesFounder
United States -
Greater Boston
Executive Leader with Business Development, Corporate Development, Marketing and deep technical background in Therapeutic Development and Diagnostic tools. Passionate about the intersection of Biology, Healthcare, and AI.
SchoolAI | $25,000,000 | (Apr 3, 2025)
Ropes | $3,100,000 | (Apr 3, 2025)
experial | $2,198,930 | (Apr 3, 2025)
Cambrian Network | $5,900,000 | (Apr 3, 2025)
Actively AI | $22,500,000 | (Apr 3, 2025)
TrialKit | $4,250,000 | (Apr 3, 2025)
Sturdy | $6,000,000 | (Apr 2, 2025)
Tomorro | $26,995,875 | (Apr 2, 2025)
voize | $9,000,000 | (Apr 2, 2025)